Search

everythinglearnresearchcommunity

for

Search:↓

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.

Personalized care and evaluation are crucial for successful plastic surgery outcomes.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Adrenal disorders often cause high blood pressure in young people.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Tattooing helps treat skin conditions, reconstruct nipple-areola, mark radiation fields, and locate lesions.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Injecting platelet-derived growth factors into ovaries may improve IVF outcomes by enhancing egg quality and embryo health.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Topical eye β-blockers may cause hair loss.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.